Tech Company Financing Transactions
Cellino Biotech Funding Round
Humboldt Fund, Leaps by Bayer and Felicis Ventures joined a $80 million Series A funding round for Cellino Biotech. The round was recorded on 2/2/2022.
Transaction Overview
Company Name
Announced On
2/2/2022
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series A
Investors
Humboldt Fund (Lead Investor)
Leaps by Bayer (Lead Investor) (Juergen Eckhardt)
Proceeds Purpose
Proceeds from the Series A financing will considerably expand Cellino's software, machine learning, and hardware capabilities for end-to-end manufacturing of both autologous and allogeneic stem cell-based therapies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
501 Mass Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
The Cellino team brings together experts in stem cell biology, machine learning, and laser optics with a mission to industrialize personalized regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nabiha Saklayen
Chief Financial Officer
Julie Androlio
Chief Technical Officer
Matthias Wagner
Vice President
George Harb
Vice President
Ozge Whiting
VP - Administration
Willie Reaves
VP - Engineering
Steven Nagle
VP - General Counsel
Yutian Ling
VP - Product Management
Marinna Madrid
Browse more venture capital transactions:
Prev: 2/2/2022: Alta Reality venture capital transaction
Next: 2/2/2022: Intellect venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs